The peripherally inserted central catheter (picc) market size has grown steadily in recent years. It will grow from $1.07 billion in 2025 to $1.12 billion in 2026 at a compound annual growth rate (CAGR) of 4.4%. The growth in the historic period can be attributed to rising incidence of chronic diseases requiring long-term iv therapy, increasing hospital adoption of picc lines for chemotherapy and antibiotic delivery, early clinical acceptance of single and double lumen conventional kits, expansion of catheterization lab services supporting vascular access, growing utilization of piccs in inpatient and critical care settings.
The peripherally inserted central catheter (picc) market size is expected to see steady growth in the next few years. It will grow to $1.32 billion in 2030 at a compound annual growth rate (CAGR) of 4.3%. The growth in the forecast period can be attributed to increasing demand for power-injectable and multi-lumen picc systems, rising usage of tip-placement kits to improve procedural accuracy, growing procedure volumes in ambulatory surgical centers, expanding application of piccs in home infusion and outpatient therapy, rising focus on reducing complications and improving long-term vascular access outcomes. Major trends in the forecast period include rising adoption of power-injectable picc lines for advanced diagnostic and therapeutic procedures, increasing utilization of multi-lumen piccs for complex long-term iv therapy, growing preference for tip-placement and navigation-assisted picc insertion kits, expansion of picc usage in oncology nutrition support and chronic infection management, increasing deployment of picc lines across hospitals ascs and catheterization laboratories.
The increasing prevalence of chronic diseases is anticipated to drive the growth of the peripherally inserted central catheter (PICC) market in the forthcoming years. Chronic diseases encompass long-term health conditions that persist over an extended period and often progress slowly, including cancer, diabetes, hypertension, stroke, heart disease, respiratory diseases, arthritis, obesity, and oral diseases. PICCs are instrumental in managing chronic conditions by providing long-term intravenous access for administering drugs, fluids, parenteral nutrition, and conducting blood draws. For example, as reported by the National Library of Medicine in January 2023, the projected number of individuals aged 50 years and older with one or more chronic illnesses is expected to increase by 99.5% in the United States, reaching 142.66 million by 2050, up from 71.522 million in 2020. Consequently, the growing prevalence of chronic diseases is fueling the demand for peripherally inserted central catheters (PICCs) and driving market growth.
Major companies in the peripherally inserted central catheter (PICC) market are concentrating on innovative technologies, such as peripherally inserted central catheter insertion devices, to enhance customer experience with advanced features. These devices are specialized medical instruments designed to facilitate the placement of PICCs into peripheral veins, typically in the arm, and guide them to larger veins near the heart. For instance, in May 2023, Teleflex Incorporated, a US-based medical device company, introduced two new insertion devices such as the Arrow VPS Rhythm DLX Device and the NaviCurve Stylet. The VPS Rhythm DLX Device utilizes cardiac electrical activity to provide real-time catheter tip position information and offers an optional integrated ultrasonography feature with a catheter-to-vessel ratio tool for consistent vessel measuring. When used with the Arrow PICC equipped with the NaviCurve Stylet, this device introduces new tip navigation technology. The VPS Rhythm DLX Device, featuring TipTracker Technology, eliminates the need for confirmatory x-rays, enabling physicians to perform smooth ultrasound vascular evaluation, peripherally inserted central catheter navigation, and final tip verification in the bottom third of the superior vena cava.
In September 2024, Access Vascular, Inc., a US-based medical technology company focused on hydrophilic biomaterial catheter solutions, formed a strategic partnership with Capstone Health Alliance for an undisclosed amount. Through this collaboration, Access Vascular seeks to broaden the use of its MIMIX portfolio of midline and PICC catheters across Capstone’s network of more than 300 hospitals, health systems, and physician practices, with the goal of enhancing vascular access performance and lowering catheter-related complications. Capstone Health Alliance is a US-based regional group purchasing organization that supports hospitals and healthcare providers through supply chain management and value-based purchasing initiatives.
Major companies operating in the peripherally inserted central catheter (picc) market are Cardinal Health Inc., Medtronic plc, Becton Dickinson and Company, B. Braun Medical Ltd, Teleflex Incorporated, ICU Medical Inc., Cook Medical, AngioDynamics, Argon Medical, PFM Medical Inc., Poly Medicure Ltd., Kimal Plc, Utah Medical Products Inc., Martech Medical Products, NeoMedical, Medical Components Inc, DeltaMed Solutions Inc., Access Vascular Inc., Medi-Tech Devices, Footprint Medical Incorporated, Biowy Corporation, Husk Medical B.V., Medcomp, Vygon Ltd, Haolang Technology (Foshan) Limited Co. Ltd.
North America was the largest region in the peripherally inserted central catheter (PICC) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peripherally inserted central catheter (picc) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the peripherally inserted central catheter (picc) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the peripherally inserted central catheter (PICC) market by increasing import and raw material costs for polymers, silicone tubing, precision connectors, and imaging-compatible components used across power-injectable and non-power-injectable product lines, resulting in higher manufacturing and procurement expenses for hospitals and catheterization laboratories. The impact is more evident in North America, Europe, and Asia-Pacific regions that rely on cross-border sourcing for multi-lumen catheters, tip-placement kits, and navigation devices used in oncology, infectious disease, and nutrition therapy settings. These higher landed costs have contributed to pricing pressure and delayed bulk purchases in cost-sensitive facilities; however, tariffs are also fostering localized assembly, regional supplier development, and near-shoring of vascular access device manufacturing, generating selective positive outcomes for domestic producers.
The peripherally inserted central catheter (picc) market research report is one of a series of new reports that provides peripherally inserted central catheter (picc) market statistics, including peripherally inserted central catheter (picc) industry global market size, regional shares, competitors with a peripherally inserted central catheter (picc) market share, detailed peripherally inserted central catheter (picc) market segments, market trends and opportunities, and any further data you may need to thrive in the peripherally inserted central catheter (picc) industry. This peripherally inserted central catheter (picc) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A peripherally inserted central catheter (PICC) is a slender, flexible tube inserted into a peripheral vein, typically in the arm, and guided until its tip reaches a larger vein near the heart known as the superior vena cava. This device is commonly employed in healthcare settings to facilitate long-term access to intravenous (IV) therapies, including chemotherapy, antibiotics, nutrition, and other medications.
The primary types of peripherally inserted central catheters (PICCs) include power-injectable and non-power-injectable variants. Power-injectable PICCs enable the rapid infusion of fluids or medications, particularly beneficial for critically ill patients. They are further classified based on lumen type into single, double, and triple-lumen configurations, along with specialized kits such as tip-placement kits and conventional kits. End-users of PICCs encompass hospitals, clinics, ambulatory surgical centers, and catheterization laboratories.
The peripherally inserted central catheter (PICC) market consists of sales of antimicrobial-coated peripherally inserted central catheters, ultrasound-guided peripherally inserted central catheters, radiopaque peripherally inserted central catheters, and MRI-compatible peripherally inserted central catheters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The peripherally inserted central catheter (picc) market size is expected to see steady growth in the next few years. It will grow to $1.32 billion in 2030 at a compound annual growth rate (CAGR) of 4.3%. The growth in the forecast period can be attributed to increasing demand for power-injectable and multi-lumen picc systems, rising usage of tip-placement kits to improve procedural accuracy, growing procedure volumes in ambulatory surgical centers, expanding application of piccs in home infusion and outpatient therapy, rising focus on reducing complications and improving long-term vascular access outcomes. Major trends in the forecast period include rising adoption of power-injectable picc lines for advanced diagnostic and therapeutic procedures, increasing utilization of multi-lumen piccs for complex long-term iv therapy, growing preference for tip-placement and navigation-assisted picc insertion kits, expansion of picc usage in oncology nutrition support and chronic infection management, increasing deployment of picc lines across hospitals ascs and catheterization laboratories.
The increasing prevalence of chronic diseases is anticipated to drive the growth of the peripherally inserted central catheter (PICC) market in the forthcoming years. Chronic diseases encompass long-term health conditions that persist over an extended period and often progress slowly, including cancer, diabetes, hypertension, stroke, heart disease, respiratory diseases, arthritis, obesity, and oral diseases. PICCs are instrumental in managing chronic conditions by providing long-term intravenous access for administering drugs, fluids, parenteral nutrition, and conducting blood draws. For example, as reported by the National Library of Medicine in January 2023, the projected number of individuals aged 50 years and older with one or more chronic illnesses is expected to increase by 99.5% in the United States, reaching 142.66 million by 2050, up from 71.522 million in 2020. Consequently, the growing prevalence of chronic diseases is fueling the demand for peripherally inserted central catheters (PICCs) and driving market growth.
Major companies in the peripherally inserted central catheter (PICC) market are concentrating on innovative technologies, such as peripherally inserted central catheter insertion devices, to enhance customer experience with advanced features. These devices are specialized medical instruments designed to facilitate the placement of PICCs into peripheral veins, typically in the arm, and guide them to larger veins near the heart. For instance, in May 2023, Teleflex Incorporated, a US-based medical device company, introduced two new insertion devices such as the Arrow VPS Rhythm DLX Device and the NaviCurve Stylet. The VPS Rhythm DLX Device utilizes cardiac electrical activity to provide real-time catheter tip position information and offers an optional integrated ultrasonography feature with a catheter-to-vessel ratio tool for consistent vessel measuring. When used with the Arrow PICC equipped with the NaviCurve Stylet, this device introduces new tip navigation technology. The VPS Rhythm DLX Device, featuring TipTracker Technology, eliminates the need for confirmatory x-rays, enabling physicians to perform smooth ultrasound vascular evaluation, peripherally inserted central catheter navigation, and final tip verification in the bottom third of the superior vena cava.
In September 2024, Access Vascular, Inc., a US-based medical technology company focused on hydrophilic biomaterial catheter solutions, formed a strategic partnership with Capstone Health Alliance for an undisclosed amount. Through this collaboration, Access Vascular seeks to broaden the use of its MIMIX portfolio of midline and PICC catheters across Capstone’s network of more than 300 hospitals, health systems, and physician practices, with the goal of enhancing vascular access performance and lowering catheter-related complications. Capstone Health Alliance is a US-based regional group purchasing organization that supports hospitals and healthcare providers through supply chain management and value-based purchasing initiatives.
Major companies operating in the peripherally inserted central catheter (picc) market are Cardinal Health Inc., Medtronic plc, Becton Dickinson and Company, B. Braun Medical Ltd, Teleflex Incorporated, ICU Medical Inc., Cook Medical, AngioDynamics, Argon Medical, PFM Medical Inc., Poly Medicure Ltd., Kimal Plc, Utah Medical Products Inc., Martech Medical Products, NeoMedical, Medical Components Inc, DeltaMed Solutions Inc., Access Vascular Inc., Medi-Tech Devices, Footprint Medical Incorporated, Biowy Corporation, Husk Medical B.V., Medcomp, Vygon Ltd, Haolang Technology (Foshan) Limited Co. Ltd.
North America was the largest region in the peripherally inserted central catheter (PICC) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peripherally inserted central catheter (picc) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the peripherally inserted central catheter (picc) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the peripherally inserted central catheter (PICC) market by increasing import and raw material costs for polymers, silicone tubing, precision connectors, and imaging-compatible components used across power-injectable and non-power-injectable product lines, resulting in higher manufacturing and procurement expenses for hospitals and catheterization laboratories. The impact is more evident in North America, Europe, and Asia-Pacific regions that rely on cross-border sourcing for multi-lumen catheters, tip-placement kits, and navigation devices used in oncology, infectious disease, and nutrition therapy settings. These higher landed costs have contributed to pricing pressure and delayed bulk purchases in cost-sensitive facilities; however, tariffs are also fostering localized assembly, regional supplier development, and near-shoring of vascular access device manufacturing, generating selective positive outcomes for domestic producers.
The peripherally inserted central catheter (picc) market research report is one of a series of new reports that provides peripherally inserted central catheter (picc) market statistics, including peripherally inserted central catheter (picc) industry global market size, regional shares, competitors with a peripherally inserted central catheter (picc) market share, detailed peripherally inserted central catheter (picc) market segments, market trends and opportunities, and any further data you may need to thrive in the peripherally inserted central catheter (picc) industry. This peripherally inserted central catheter (picc) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A peripherally inserted central catheter (PICC) is a slender, flexible tube inserted into a peripheral vein, typically in the arm, and guided until its tip reaches a larger vein near the heart known as the superior vena cava. This device is commonly employed in healthcare settings to facilitate long-term access to intravenous (IV) therapies, including chemotherapy, antibiotics, nutrition, and other medications.
The primary types of peripherally inserted central catheters (PICCs) include power-injectable and non-power-injectable variants. Power-injectable PICCs enable the rapid infusion of fluids or medications, particularly beneficial for critically ill patients. They are further classified based on lumen type into single, double, and triple-lumen configurations, along with specialized kits such as tip-placement kits and conventional kits. End-users of PICCs encompass hospitals, clinics, ambulatory surgical centers, and catheterization laboratories.
The peripherally inserted central catheter (PICC) market consists of sales of antimicrobial-coated peripherally inserted central catheters, ultrasound-guided peripherally inserted central catheters, radiopaque peripherally inserted central catheters, and MRI-compatible peripherally inserted central catheters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Peripherally Inserted Central Catheter (PICC) Market Characteristics
3. Peripherally Inserted Central Catheter (PICC) Market Supply Chain Analysis
4. Global Peripherally Inserted Central Catheter (PICC) Market Trends and Strategies
5. Peripherally Inserted Central Catheter (PICC) Market Analysis of End Use Industries
7. Global Peripherally Inserted Central Catheter (PICC) Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Peripherally Inserted Central Catheter (PICC) Total Addressable Market (TAM) Analysis for the Market
9. Peripherally Inserted Central Catheter (PICC) Market Segmentation
10. Peripherally Inserted Central Catheter (PICC) Market Regional and Country Analysis
11. Asia-Pacific Peripherally Inserted Central Catheter (PICC) Market
12. China Peripherally Inserted Central Catheter (PICC) Market
13. India Peripherally Inserted Central Catheter (PICC) Market
14. Japan Peripherally Inserted Central Catheter (PICC) Market
15. Australia Peripherally Inserted Central Catheter (PICC) Market
16. Indonesia Peripherally Inserted Central Catheter (PICC) Market
17. South Korea Peripherally Inserted Central Catheter (PICC) Market
18. Taiwan Peripherally Inserted Central Catheter (PICC) Market
19. South East Asia Peripherally Inserted Central Catheter (PICC) Market
20. Western Europe Peripherally Inserted Central Catheter (PICC) Market
21. UK Peripherally Inserted Central Catheter (PICC) Market
22. Germany Peripherally Inserted Central Catheter (PICC) Market
23. France Peripherally Inserted Central Catheter (PICC) Market
24. Italy Peripherally Inserted Central Catheter (PICC) Market
25. Spain Peripherally Inserted Central Catheter (PICC) Market
26. Eastern Europe Peripherally Inserted Central Catheter (PICC) Market
27. Russia Peripherally Inserted Central Catheter (PICC) Market
28. North America Peripherally Inserted Central Catheter (PICC) Market
29. USA Peripherally Inserted Central Catheter (PICC) Market
30. Canada Peripherally Inserted Central Catheter (PICC) Market
31. South America Peripherally Inserted Central Catheter (PICC) Market
32. Brazil Peripherally Inserted Central Catheter (PICC) Market
33. Middle East Peripherally Inserted Central Catheter (PICC) Market
34. Africa Peripherally Inserted Central Catheter (PICC) Market
36. Peripherally Inserted Central Catheter (PICC) Market Competitive Landscape and Company Profiles
37. Peripherally Inserted Central Catheter (PICC) Market Other Major and Innovative Companies
40. Peripherally Inserted Central Catheter (PICC) Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Peripherally Inserted Central Catheter (PICC) Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses peripherally inserted central catheter (picc) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for peripherally inserted central catheter (picc)? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The peripherally inserted central catheter (picc) market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Device Type: Power-Injectable; Non-Power Injectable2) By Lumen Type: Single; Double; Triple
3) By Kit Type: Tip-Placement Kit; Conventional Kit
4) By End User: Hospitals and Clinics; Ambulatory Surgical Centers; Catheterization Laboratories
Subsegments:
1) By Power-Injectable PICCs: Single Lumen Power-Injectable PICCs; Double Lumen Power-Injectable PICCs; Triple Lumen Power-Injectable PICCs2) By Non-Power Injectable PICCs: Single Lumen Non-Power Injectable PICCs; Double Lumen Non-Power Injectable PICCs; Triple Lumen Non-Power Injectable PICCs
Companies Mentioned: Cardinal Health Inc.; Medtronic plc; Becton Dickinson and Company; B. Braun Medical Ltd; Teleflex Incorporated; ICU Medical Inc.; Cook Medical; AngioDynamics; Argon Medical; PFM Medical Inc.; Poly Medicure Ltd.; Kimal Plc; Utah Medical Products Inc.; Martech Medical Products; NeoMedical; Medical Components Inc; DeltaMed Solutions Inc.; Access Vascular Inc.; Medi-Tech Devices; Footprint Medical Incorporated; Biowy Corporation; Husk Medical B.V.; Medcomp; Vygon Ltd; Haolang Technology (Foshan) Limited Co. Ltd
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Peripherally Inserted Central Catheter (PICC) market report include:- Cardinal Health Inc.
- Medtronic plc
- Becton Dickinson and Company
- B. Braun Medical Ltd
- Teleflex Incorporated
- ICU Medical Inc.
- Cook Medical
- AngioDynamics
- Argon Medical
- PFM Medical Inc.
- Poly Medicure Ltd.
- Kimal Plc
- Utah Medical Products Inc.
- Martech Medical Products
- NeoMedical
- Medical Components Inc
- DeltaMed Solutions Inc.
- Access Vascular Inc.
- Medi-Tech Devices
- Footprint Medical Incorporated
- Biowy Corporation
- Husk Medical B.V.
- Medcomp
- Vygon Ltd
- Haolang Technology (Foshan) Limited Co. Ltd
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.12 Billion |
| Forecasted Market Value ( USD | $ 1.32 Billion |
| Compound Annual Growth Rate | 4.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 26 |
